Breaking
Danaher names Julie Sawyer Montgomery new CEO
Live Outbreaks

Danaher names Julie Sawyer Montgomery new CEO

Nabilah Razak · 05/08/2026

Danaher names Julie Sawyer Montgomery as new CEO to lead the company's diagnostics business and growth strategy effectively.

Crisis Cams

Crisis Cams →
FDA Reconsiders Its Use of Artificial Intelligence
Crisis Cams

FDA Reconsiders Its Use of Artificial Intelligence

FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.

+

More News

Danaher names Julie Sawyer Montgomery new CEO
Live Outbreaks

Danaher names Julie Sawyer Montgomery as new CEO to lead the company's diagnostics business and growth strategy effectively.

05/08/2026
DeepHealth’s AI Ultrasound Tool Wins FDA Approval
Health Streams

AI ultrasound tool from DeepHealth gains FDA 510(k) clearance, offering breast scan analysis and draft reports to aid…

05/08/2026
Siemens Healthineers Appoints New Americas Chief
Field Reports

Siemens Healthineers appoints new Americas chief,João Seabra, to lead its largest market amidst diagnostics challenges.

04/08/2026
Schein Ousts Three Top Executives Suddenly
Field Reports

Schein ousts top executives suddenly to simplify business and improve execution on its goals with new leadership team.

04/08/2026
Siemens Healthineers and Cleveland Clinic partner for decade
Aid Ops

Siemens Healthineers and Cleveland Clinic extend their 10-year partnership to advance diagnostic and therapeutic technologies for better patient…

03/08/2026
Robotic microsurgery tested for Alzheimer’s treatment
Health Streams

Robotic microsurgery is being tested for Alzheimer's treatment with FDA clearance for expanded enrollment in a feasibility trial…

03/08/2026
Stryker recovers from recent cyber attack
Field Reports

Stryker recovers from recent cyber attack that disrupted operations and affected first-quarter results.

02/08/2026
FDA Reconsiders Its Use of Artificial Intelligence
Crisis Cams

FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.

01/08/2026
J&J’s Ottava robot advances surgical precision
Crisis Cams

Johnson & Johnson’s Ottava surgical robot gains FDA clearance, boosting precision in general surgery and challenging da Vinci’s…

31/07/2026
Medtronic backs CoreMap with $37M funding
Crisis Cams

Medtronic invests $37M in CoreMap to advance cardiac mapping technology for precise AFib treatment, improving ablation outcomes.

31/07/2026